Status:
COMPLETED
Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors
Lead Sponsor:
Oticon Medical
Conditions:
Sensorineural Hearing Loss
Cochlear Hearing Loss
Eligibility:
All Genders
Phase:
NA
Brief Summary
The present study aims to evaluate patient satisfaction and audiological performance with their current cochlear implant speech processor, the Neuro 1, and to compare it with the satisfaction and perf...
Detailed Description
Nowadays, cochlear implants (CI) are successfully used to rehabilitate severe to profound sensorineural hearing loss. Oticon Medical recently developed a new cochlear implant system, including a new i...
Eligibility Criteria
Inclusion
- informed consent
- Native French speaker or fluent French speaker
- Patient already fitted with one or two speech processor Neuro 1 for at least 5 months
Exclusion
- vulnerable patients, at the exception of children (pregnant women, persons under guardianship)
- No Social security affiliation
- non-compliant patient
Key Trial Info
Start Date :
October 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 11 2019
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT03288753
Start Date
October 2 2017
End Date
January 11 2019
Last Update
March 23 2023
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Pellegrin
Bordeaux, France, 33000
2
Hôpital Roger Salengro
Lille, France, 59037
3
Hôpital Edouard Herriot
Lyon, France, 69003
4
CHRU de Nancy Hôpital central
Nancy, France, 54035